Over the last 10 years, West Pharmaceutical Services stock has attracted buying interest at this level 7 times and has ...
Zacks Investment Research on MSN
Reasons to add West Pharmaceutical stock to your portfolio now
West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by a robust GLP-1-related demand and expansion ...
As of Friday, January 30, Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 16.32%, which has investors ...
There might be massive upside ahead for these drugmakers.
Investor's Business Daily on MSN
Stocks to watch: Tarsus Pharmaceuticals sees RS rating rise to 81
Tarsus Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.
Pfizer's deal with the U.S. government, a robust pipeline, and a reasonable valuation make it a compelling buy. Eli Lilly's fantastic financial results and impressive innovative abilities paint a ...
NewAmsterdam Pharma Co (NASDAQ: NAMS) has been analyzed by 5 analysts in the last three months, revealing a diverse range of ...
SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...
10d
Stock Market Today, Jan. 20: Corvus Pharmaceuticals Surges After Positive Phase 1 Eczema Drug Data
Early eczema trial success and heavy trading are rapidly reshaping how investors view this drug developer, today, Jan. 20, 2026.
Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $508.25, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results